Gao Y et al. [43] demonstrated that SARS-CoV-2 spike-specific CD4+ and CD8+ T cells elicited by BNT162B2 vaccination or previous infection remain largely intact against the Omicron variant. This evidence concerns the gene CD8A and infection.